These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34571712)

  • 1. Liver Organoids: Updates on Disease Modeling and Biomedical Applications.
    Caiazza C; Parisi S; Caiazzo M
    Biology (Basel); 2021 Aug; 10(9):. PubMed ID: 34571712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human chemically-derived hepatic progenitors (hCdHs) as a source of liver organoid generation: Application in regenerative medicine, disease modeling, and toxicology testing.
    Salas-Silva S; Kim Y; Kim TH; Kim M; Seo D; Choi J; Factor VM; Seo HR; Song Y; Choi GS; Jung YK; Kim K; Lee KG; Jeong J; Shin JH; Choi D
    Biomaterials; 2023 Dec; 303():122360. PubMed ID: 38465578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges for the Applications of Human Pluripotent Stem Cell-Derived Liver Organoids.
    Chang M; Bogacheva MS; Lou YR
    Front Cell Dev Biol; 2021; 9():748576. PubMed ID: 34660606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging interacting signaling pathways to robustly improve the quality and yield of human pluripotent stem cell-derived hepatoblasts and hepatocytes.
    Raggi C; M'Callum MA; Pham QT; Gaub P; Selleri S; Baratang NV; Mangahas CL; Cagnone G; Reversade B; Joyal JS; Paganelli M
    Stem Cell Reports; 2022 Mar; 17(3):584-598. PubMed ID: 35120625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine.
    Olgasi C; Cucci A; Follenzi A
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cells, organoids and their applications for human diseases: Special issue of BMB Reports in 2023.
    Shin K
    BMB Rep; 2023 Jan; 56(1):1. PubMed ID: 36698280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling human liver organ development and diseases with pluripotent stem cell-derived organoids.
    Ouchi R; Koike H
    Front Cell Dev Biol; 2023; 11():1133534. PubMed ID: 36875751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases.
    Nikokiraki C; Psaraki A; Roubelakis MG
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems.
    Silva-Pedrosa R; Salgado AJ; Ferreira PE
    Cells; 2023 Mar; 12(6):. PubMed ID: 36980271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system.
    Wang Y; Wang H; Deng P; Chen W; Guo Y; Tao T; Qin J
    Lab Chip; 2018 Dec; 18(23):3606-3616. PubMed ID: 30357207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Organoids: Formation Strategies and Biomedical Applications.
    Zhu X; Zhang B; He Y; Bao J
    Tissue Eng Regen Med; 2021 Aug; 18(4):573-585. PubMed ID: 34132985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organoids to model liver disease.
    Nuciforo S; Heim MH
    JHEP Rep; 2021 Feb; 3(1):100198. PubMed ID: 33241206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Complex Syngeneic Liver Organoids from Induced Pluripotent Stem Cells to Model Human Liver Pathophysiology.
    Raggi C; Selleri S; M'Callum MA; Paganelli M
    Curr Protoc; 2022 Mar; 2(3):e389. PubMed ID: 35263041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Merits and challenges of iPSC-derived organoids for clinical applications.
    Xu Z; Yang J; Xin X; Liu C; Li L; Mei X; Li M
    Front Cell Dev Biol; 2023; 11():1188905. PubMed ID: 37305682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in organoid development and applications in disease modeling.
    Rauth S; Karmakar S; Batra SK; Ponnusamy MP
    Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188527. PubMed ID: 33640383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver diseases in the dish: iPSC and organoids as a new approach to modeling liver diseases.
    Fiorotto R; Amenduni M; Mariotti V; Fabris L; Spirli C; Strazzabosco M
    Biochim Biophys Acta Mol Basis Dis; 2019 May; 1865(5):920-928. PubMed ID: 30264693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver organoids: from basic research to therapeutic applications.
    Prior N; Inacio P; Huch M
    Gut; 2019 Dec; 68(12):2228-2237. PubMed ID: 31300517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cell-Derived Organoids in Regenerative Medicine.
    Lee H; Son MY
    Int J Stem Cells; 2021 Feb; 14(1):9-20. PubMed ID: 33632980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-Generation Liver Medicine Using Organoid Models.
    Akbari S; Arslan N; Senturk S; Erdal E
    Front Cell Dev Biol; 2019; 7():345. PubMed ID: 31921856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.